The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kerstan, A.
Right arrow Articles by Hünig, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kerstan, A.
Right arrow Articles by Hünig, T.
The Journal of Immunology, 2006, 177: 7689-7697.
Copyright © 2006 by The American Association of Immunologists, Inc.

Cyclosporin A Abolishes CD28-Mediated Resistance to CD95-Induced Apoptosis via Superinduction of Caspase-31

Andreas Kerstan*,{dagger}, Nicole Armbruster{dagger}, Martin Leverkus{dagger},{ddagger} and Thomas Hünig2,*

* Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany; {dagger} Department of Dermatology, University of Würzburg, Würzburg, Germany; and {ddagger} Laboratory for Experimental Dermatology, Department of Dermatology and Venerology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany

Costimulation of T cells via CD28 promotes both proliferation and resistance to apoptosis. In this study, we show that the immunosuppressive drug cyclosporin A (CsA) fully reverses resistance to CD95-mediated cell death after TCR/CD28 costimulation or superagonistic anti-CD28 mAb stimulation of primary rat lymph node T cells. This effect correlated with a pronounced superinduction of caspase-3 on both mRNA and protein levels, whereas its main antagonist, X chromosome-linked inhibitor of apoptosis, was unaffected by inclusion of CsA. Apoptosis triggered by CD95 cross-linking was characterized by robust caspase-3 activation. Furthermore, CsA sensitization to CD95-mediated apoptosis of CD28-activated T cells did not alter mRNA stability of superinduced caspase-3 mRNA, suggesting a transcriptional regulation of the caspase-3 gene. Addition of Ca2+ ionophores to TCR/CD28 or superagonistic CD28-stimulated cells reduced caspase-3 levels, further supporting a role for Ca2+-dependent signaling pathways in negatively regulating caspase-3. Taken together, these findings suggest that CsA promotes sensitivity to CD95-mediated apoptosis in CD28-stimulated T cells by superinduction of the caspase-3 gene via a mechanism involving suppression of the calcineurin pathway.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by the Deutsche Forschungsgemeinschaft through the Graduiertenkolleg 520 Immunmodulation and Hu 295/8-1, and by TeGenero. M.L. was supported by Deutsche Forschungsgemeinschaft (Le 953 4/1) and Deutsche Krebshilfe (106849).

2 Address correspondence and reprint requests to Dr. Thomas Hünig, Institute for Virology and Immunobiology, University of Würzburg, Versbacher Strasse 7, D-97078 Würzburg, Germany. E-mail address: huenig{at}vim.uni-wuerzburg.de

3 Abbreviations used in this paper: AICD, activation-induced cell death; CD95L, CD95 ligand; CDK4, cyclin-dependent kinase 4; CsA, cyclosporin A; pAb, polyclonal Ab; sCD95L, soluble CD95L; XIAP, X chromosome-linked inhibitor of apoptosis.




This article has been cited by other articles:


Home page
BloodHome page
N. Ueffing, M. Schuster, E. Keil, K. Schulze-Osthoff, and I. Schmitz
Up-regulation of c-FLIPshort by NFAT contributes to apoptosis resistance of short-term activated T cells
Blood, August 1, 2008; 112(3): 690 - 698.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.